论文部分内容阅读
目的:探究和分析氧气驱动雾化吸入治疗支气管哮喘急性发作的临床效果。方法:以我院2014年2月份到2015年4月份收治的支气管哮喘急性发作患者80例为研究对象。随机分成对照组和实验组,各40例。对照组给予常规治疗,实验组增加氧气驱动雾化吸入治疗。观察和对比两组患者的治疗情况。结果:实验组的总有效率比对照组高,差异性显著,P<0.05,统计学意义成立;实验组治疗后的最大呼气流量、SPO_2情况优于对照组,差异性显著,P<0.05,统计学意义成立;实验组的症状消失时间比对照组短,差异明显,P<0.05,统计学意义成立。结论:应用氧气驱动雾化吸入对支气管哮喘急性发作进行治疗,能够有效改善患者的症状,改善病情,值得推荐。
Objective: To investigate and analyze the clinical effect of aerosol inhalation in the treatment of acute exacerbation of bronchial asthma. Methods: Eighty patients with acute exacerbation of bronchial asthma admitted in our hospital from February 2014 to April 2015 were enrolled in this study. Randomly divided into control group and experimental group, 40 cases each. Control group given conventional treatment, experimental group increased oxygen-driven inhalation therapy. Observed and compared the treatment of two groups of patients. Results: The total effective rate of the experimental group was higher than the control group, the difference was significant, P <0.05, the statistical significance was established; the maximum expiratory flow after treatment in the experimental group, SPO_2 better than the control group, the difference was significant, P <0.05 , The statistical significance was established. The symptom disappearance time in the experimental group was shorter than that in the control group, with significant difference (P <0.05). The statistical significance was established. Conclusion: Oxygen-driven aerosol inhalation for the treatment of acute exacerbation of bronchial asthma can effectively improve the symptoms and improve the condition of patients, which is worth recommending.